Proactive Investors interview with the Open Orphan #ORPH team on its future and ‘the lottery ticket’ sitting within hVIVO February 4, 2020 – Posted in: Open Orphan (ORPH) – Tags: andrew scott, Andrew Scott TV, Cathal Friel, coronavirus, hVIVO, Open Orphan, open orphan hvivo merger, ORPH, proactive investors, professor john oxford

Open Orphan PLC‘s (LON:ORPH) Cathal Friel speaks to Proactive London’s Andrew Scott following the completion last week of its £5.3mln fundraise.

Also in studio is adviser to Open Orphan and founder of hVivo Professor John Oxford.

Professor Oxford’s been a leader in the field of vaccine and anti-viral clinical trials for the last 20 years.

hVivo, which has recently been acquired by Open Orphan, owns the largest commercial quarantine clinic in northern Europe and could play a role in treating patients affected by the recent outbreak of coronavirus.